跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIFAREN 300 CAPSULE 300 mg - HSA Drug Approval Details
Approvals
/
HSA
/
RIFAREN 300 CAPSULE 300 mg
Approved
THERAPEUTIC
RIFAREN 300 CAPSULE 300 mg
REMEDICA LTD
🇸🇬 Health Sciences Authority
Approval Date
Sep 13, 1998
Approval ID
a0822823d0ce1769
Company
REMEDICA LTD
Type
Therapeutic
Approval Details
Approval Id
a0822823d0ce1769
Drug Name
RIFAREN 300 CAPSULE 300 mg
Product Name
RIFAREN 300 CAPSULE 300 mg
Approval Number
SIN10052P
Approval Date
1998-09-13
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
J04AB02
Atc Item Name
rifampicin
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
RIFAMPICIN
300 mg
RIFAMPICIN
300 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 13, 1998
Approval ID
a0822823d0ce1769
Type
Therapeutic
Back to HSA Approvals